Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69


Legislative, educational, policy and other interventions targeting physicians' interaction with pharmaceutical companies: a systematic review.

Alkhaled L, Kahale L, Nass H, Brax H, Fadlallah R, Badr K, Akl EA.

BMJ Open. 2014 Jul 1;4(7):e004880. doi: 10.1136/bmjopen-2014-004880. Review.


Association between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis.

Brax H, Fadlallah R, Al-Khaled L, Kahale LA, Nas H, El-Jardali F, Akl EA.

PLoS One. 2017 Apr 13;12(4):e0175493. doi: 10.1371/journal.pone.0175493. eCollection 2017. Review.


Knowledge, beliefs and attitudes of physicians in low and middle-income countries regarding interacting with pharmaceutical companies: a systematic review.

Lotfi T, Morsi RZ, Rajabbik MH, Alkhaled L, Kahale L, Nass H, Brax H, Fadlallah R, Akl EA.

BMC Health Serv Res. 2016 Feb 17;16:57. doi: 10.1186/s12913-016-1299-4. Review.


Extent of physician-pharmaceutical industry interactions in low- and middle-income countries: a systematic review.

Fadlallah R, Alkhaled L, Brax H, Nasser M, Rajabbik MH, Nass H, Kahale LA, Akl EA.

Eur J Public Health. 2017 Nov 20. doi: 10.1093/eurpub/ckx204. [Epub ahead of print]


Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review.

Fadlallah R, Nas H, Naamani D, El-Jardali F, Hammoura I, Al-Khaled L, Brax H, Kahale L, Akl EA.

PLoS One. 2016 Aug 24;11(8):e0160540. doi: 10.1371/journal.pone.0160540. eCollection 2016. Review.


Validity of tools used for surveying physicians about their interactions with pharmaceutical company: a systematic review.

Lotfi T, Morsi RZ, Zmeter N, Godah MW, Alkhaled L, Kahale LA, Nass H, Brax H, Fadlallah R, Akl EA.

BMC Res Notes. 2015 Nov 25;8:720. doi: 10.1186/s13104-015-1709-4.


Characterizing the interaction between physicians, pharmacists and pharmaceutical representatives in a middle-income country: A qualitative study.

Hajjar R, Bassatne A, Cheaito MA, Naser El Dine R, Traboulsy S, Haddadin F, Honein-AbouHaidar G, Akl EA.

PLoS One. 2017 Sep 12;12(9):e0184662. doi: 10.1371/journal.pone.0184662. eCollection 2017.


Physicians' perceptions of medical representative visits in Yemen: a qualitative study.

Al-Areefi MA, Hassali MA, Ibrahim MI.

BMC Health Serv Res. 2013 Aug 20;13:331. doi: 10.1186/1472-6963-13-331.


Residency Curricula on Physician-Pharmaceutical Industry Interaction: A CERA Study.

Evans DV, Waters RC, Olsen C, Stephens MB, Brown SR.

Fam Med. 2016 Jan;48(1):44-8.


Interaction and medical inducement between pharmaceutical representatives and physicians: a meta-synthesis.

Salmasi S, Ming LC, Khan TM.

J Pharm Policy Pract. 2016 Nov 17;9:37. eCollection 2016. Review.


Turkish Final Year Medical Students' Exposure to and Attitudes Concerning Drug Company Interactions: A Perspective from a Minimally Regulated Environment for Medical Students.

Beyhun NE, Kolayli CC, Can G, Topbas M.

PLoS One. 2016 Dec 15;11(12):e0168094. doi: 10.1371/journal.pone.0168094. eCollection 2016.


Exposure to the drug company marketing in Greece: Interactions and attitudes in a non-regulated environment for medical students.

Filippiadou M, Kouvelas D, Garyfallos G, Tsakiridis I, Tzachanis D, Spachos D, Papazisis G.

Ann Med Surg (Lond). 2017 May 29;19:23-28. doi: 10.1016/j.amsu.2017.05.013. eCollection 2017 Jul.


What do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives?

Alssageer MA, Kowalski SR.

Pan Afr Med J. 2013 Apr 6;14:132. doi: 10.11604/pamj.2013.14.132.2598. Print 2013.


Polish physicians' cooperation with the pharmaceutical industry and its potential impact on public health.

Makowska M.

PLoS One. 2017 Sep 19;12(9):e0184862. doi: 10.1371/journal.pone.0184862. eCollection 2017.


Interventions to combat or prevent drug counterfeiting: a systematic review.

El-Jardali F, Akl EA, Fadlallah R, Oliver S, Saleh N, El-Bawab L, Rizk R, Farha A, Hamra R.

BMJ Open. 2015 Mar 18;5(3):e006290. doi: 10.1136/bmjopen-2014-006290. Review.


Relationships between authors of clinical practice guidelines and the pharmaceutical industry.

Choudhry NK, Stelfox HT, Detsky AS.

JAMA. 2002 Feb 6;287(5):612-7.


Supplemental Content

Support Center